Ken Fujiwara
Director/Board Member chez MITSUBISHI CHEMICAL GROUP CORPORATION
Profil
Actuellement, Ken Fujiwara est directeur et chef de la conformité chez Mitsubishi Chemical Holdings Corp. et chef de la direction de Mitsubishi Chemical Holdings Europe GmbH (une filiale de Mitsubishi Chemical Holdings Corp.). M. Fujiwara est également membre du conseil d'administration de Mitsubishi Tanabe Pharma Corp. Ken Fujiwara a précédemment occupé le poste de Chief Executive Officer de Mitsubishi Chemical Holdings America, Inc.
Postes actifs de Ken Fujiwara
| Sociétés | Poste | Début |
|---|---|---|
| MITSUBISHI CHEMICAL GROUP CORPORATION | Director/Board Member | 26/06/2018 |
| MITSUBISHI TANABE PHARMA CORPORATION | Director/Board Member | - |
Mitsubishi Chemical Corp.
 Mitsubishi Chemical Corp. Chemicals: Major DiversifiedProcess Industries Mitsubishi Chemical Corp. engages in the manufacture and sale of performance products and industrial materials. Its products and materials are used in automobiles and aircrafts; packaging, labels and films; IT, electronics and displays; environment and energy; and medical, food and bio products. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan. | Director/Board Member | 01/04/2022 |
Anciens postes connus de Ken Fujiwara
| Sociétés | Poste | Fin |
|---|---|---|
Mitsubishi Chemical Holdings America, Inc.
 Mitsubishi Chemical Holdings America, Inc. Chemicals: Major DiversifiedProcess Industries Part of Mitsubishi Chemical Group Corp., Mitsubishi Chemical Holdings America, Inc. is a private company that manufactures and supplies chemical products. The company is based in New York, NY. | Chief Executive Officer | 01/03/2019 |
Mitsubishi Chemical Holdings Europe GmbH
 Mitsubishi Chemical Holdings Europe GmbH Chemicals: SpecialtyProcess Industries Part of Mitsubishi Chemical Group Corp., Mitsubishi Chemical Holdings Europe GmbH is a German company that manufactures synthetic resins and plastics materials. The company is based in Wiesbaden, Germany. The CEOs are Ken Fujiwara, Naohisa Hashimoto. The private company was founded in 2013. | Chief Executive Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MITSUBISHI CHEMICAL GROUP CORPORATION | Process Industries |
| Entreprise privées | 4 |
|---|---|
Mitsubishi Tanabe Pharma Corp.
 Mitsubishi Tanabe Pharma Corp. Pharmaceuticals: OtherHealth Technology Mitsubishi Tanabe Pharma Corp. engages in the research, development, manufacture, and sale of pharmaceutical products. Its products include Remicade, Ceredist, Talion, Kremezin, Maintate, Simponi, Lexapro, Tenelia, Tetrabik, and Imusera. The company was founded by Gohei Tanabeya in 1678 and is headquartered in Osaka, Japan. | Health Technology |
Mitsubishi Chemical Corp.
Mitsubishi Chemical Corp. Chemicals: Major DiversifiedProcess Industries Mitsubishi Chemical Corp. engages in the manufacture and sale of performance products and industrial materials. Its products and materials are used in automobiles and aircrafts; packaging, labels and films; IT, electronics and displays; environment and energy; and medical, food and bio products. The company was founded on August 31, 1933 and is headquartered in Tokyo, Japan. | Process Industries |
Mitsubishi Chemical Holdings America, Inc.
Mitsubishi Chemical Holdings America, Inc. Chemicals: Major DiversifiedProcess Industries Part of Mitsubishi Chemical Group Corp., Mitsubishi Chemical Holdings America, Inc. is a private company that manufactures and supplies chemical products. The company is based in New York, NY. | Process Industries |
Mitsubishi Chemical Holdings Europe GmbH
Mitsubishi Chemical Holdings Europe GmbH Chemicals: SpecialtyProcess Industries Part of Mitsubishi Chemical Group Corp., Mitsubishi Chemical Holdings Europe GmbH is a German company that manufactures synthetic resins and plastics materials. The company is based in Wiesbaden, Germany. The CEOs are Ken Fujiwara, Naohisa Hashimoto. The private company was founded in 2013. | Process Industries |
